BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11895790)

  • 21. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.
    Gille H; Kowalski J; Li B; LeCouter J; Moffat B; Zioncheck TF; Pelletier N; Ferrara N
    J Biol Chem; 2001 Feb; 276(5):3222-30. PubMed ID: 11058584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.
    Shen BQ; Lee DY; Cortopassi KM; Damico LA; Zioncheck TF
    J Biol Chem; 2001 Feb; 276(7):5281-6. PubMed ID: 11058594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors.
    Tsopanoglou NE; Maragoudakis ME
    J Biol Chem; 1999 Aug; 274(34):23969-76. PubMed ID: 10446165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
    Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
    J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2.
    Backer MV; Budker VG; Backer JM
    J Control Release; 2001 Jul; 74(1-3):349-55. PubMed ID: 11489517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial wall products induce downregulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: implications for surgical wound healing.
    Power C; Wang JH; Sookhai S; Street JT; Redmond HP
    J Surg Res; 2001 Dec; 101(2):138-45. PubMed ID: 11735268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D; Lamy S; Béliveau R
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF as a mediator of tumor-associated immunodeficiency.
    Ohm JE; Carbone DP
    Immunol Res; 2001; 23(2-3):263-72. PubMed ID: 11444391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways.
    Santos SC; Dias S
    Blood; 2004 May; 103(10):3883-9. PubMed ID: 14726393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
    Takahashi T; Ueno H; Shibuya M
    Oncogene; 1999 Apr; 18(13):2221-30. PubMed ID: 10327068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells.
    Brouet A; Sonveaux P; Dessy C; Balligand JL; Feron O
    J Biol Chem; 2001 Aug; 276(35):32663-9. PubMed ID: 11425855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
    Price DJ; Miralem T; Jiang S; Steinberg R; Avraham H
    Cell Growth Differ; 2001 Mar; 12(3):129-35. PubMed ID: 11306513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
    Hata Y; Rook SL; Aiello LP
    Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
    Shen BQ; Lee DY; Zioncheck TF
    J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
    Rissanen TT; Vajanto I; Hiltunen MO; Rutanen J; Kettunen MI; Niemi M; Leppänen P; Turunen MP; Markkanen JE; Arve K; Alhava E; Kauppinen RA; Ylä-Herttuala S
    Am J Pathol; 2002 Apr; 160(4):1393-403. PubMed ID: 11943724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.